Search
Thursday 28 May 2015
  • :
  • :

Most Active Stocks To Watch List: AT&T, Inc. (NYSE:T), Pfizer Inc. (NYSE:PFE), Rite Aid Corporation (NYSE:RAD), Lightbridge Corp. (NASDAQ:LTBR)

On Monday, Shares of AT&T, Inc. (NYSE:T), gained 1.57% to $34.87, after the telecom behemoth revealed it struck deals with eight automakers to equip vehicles with Internet access capability and offer free and paid content exclusively for these cars.

AT&T Inc. provides telecommunications services in the United States and internationally. The company operates through two segments, Wireless and Wireline. The Wireless segment offers data and voice services, counting local, long-distance, and network access services, in addition to roaming services to youth, family, professionals, small businesses, government, and business customers.

Shares of Pfizer Inc. (NYSE:PFE), declined -0.03% to $33.98, during its last trading session.

Pfizer’s stock had its “buy” rating restated by equities research analysts at Deutsche Bank in a research note issued to investors on Wednesday. They presently have a $41.00 price target on the stock. Deutsche Bank’s target price would indicate a potential upside of 22.28% from the company’s current price.

The short interest data has been released for the April 30 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through clinical trials.

The April 30 short interest data have been contrast with the previous figures, and for the selected stocks, short interest is mixed.

Pfizer Inc. (NYSE: PFE) saw its short interest decrease to 88.8 million shares from the previous 109.6 million. Since February, short interest has been incredibly elevated, and the current reading is just backing off of this. The highest short interest reading on the year was 207.4 million. Shares of Pfizer closed Monday at $33.96, within a 52-week trading range of $27.51 to $35.53.

Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.

At the end of Monday’s trade, Shares of Rite Aid Corporation (NYSE:RAD), gained 1.69% to $8.43.

Rite Aid Corporation, has launched a new integrated marketing campaign in support of wellness+ with Plenti. As a part of Plenti, the nation’s first coalition loyalty program, Rite Aid now offers its nearly 25 million active wellness+ members even more ways to earn and enjoy savings on top of the existing wellness+ benefits they presently receive.

The campaign, created by Rite Aid’s long-time agency partner MARC USA, shows how consumers can benefit from Rite Aid joining forces with their other favorite brands. The campaign is designed to reach not only Rite Aid customers but also customers of other Plenti partners counting AT&T, Exxon, Macy’s, Mobil, Nationwide, Direct Energy, Enterprise Rent-A-Car and Hulu.

The new campaign features a 30-second TV spot that brings the coalition experience to life as it shows how wellness+ with Plenti works. It follows a shopper eagerly offering to buy a cold remedy for her sick husband. Along the way, she visits several Plenti partners for things she wants and needs, counting Macy’s for jeans, AT&T for headphones and Exxon/Mobil for fuel, before she arrives at Rite Aid – where she ultimately gets the cold medicine free with the Plenti points she has already earned.

Rite Aid Corporation, through its auxiliaries, operates a chain of retail drugstores in the United States. The company sells prescription drugs and a range of other merchandise, counting over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.

Finally, Lightbridge Corp. (NASDAQ:LTBR), ended its last trade with 29.50% surge, and closed at $1.80.

The U.S. Nuclear Regulatory Commission (NRC) revealed recently that four U.S. electric utility companies representing nearly 50% of the nation’s nuclear generation have formally asked the Commission to prepare to review the patented metallic fuel design of Lightbridge Corp, citing opportunities for this fuel product to “significantly improve safety and fuel cycle economics” of nuclear power plants. The NRC relies on communications from U.S. utilities to adjust Commission staffing levels and budgets in anticipation of regulatory review of licensing applications.

The utilities said their joint letter was being presented in advance of an predictable application to the NRC in 2017 for use of Lightbridge fuel lead test assemblies in an “operating U.S. pressurized water reactor as early as 2020.”

Lightbridge Corporation operates as a nuclear fuel technology company worldwide. It operates in two segments, Technology and Consulting. The company engages in the design and development of proprietary nuclear fuels. It offers all-metal fuel for operating and new build reactors; all-uranium seed and blanket fuel for existing plants and new build reactors; and thorium-based seed and blanket fuel for existing and new build reactors.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *